Without clinical trials we cannot expect to see any advancements in medicine; and to participate in one, patients need to be aware of ongoing trials. The National Cancer Institute (NCI) HINTS (Health Information Trends Survey, hints.cancer.gov)…
Patient recruitment has always been an Achilles heel in the success of clinical trials. As Stuart Horowitz, President of Institutions and Institutional Services, WIRB-Copernicus Group cites “The greatest challenge for multicenter clinical trials is the timely…
Research has shown that treatment outcomes are better when patients are actively engaged in their treatment and treatment decisions. So, is the healthcare industry game for patient engagement? Gamification in healthcare has been talked about as…
We are excited to announce that last month our online patient-recruitment platform iConnect 2.0 went live with CenterWatch. Clinical trials professionals as well as patients trust CenterWatch to get any information related to clinical trials. It…
Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) – it…
TrialX is excited to participate and present in AMIA 2017, the 41st anniversary of the annual symposia conducted by the American Medical Informatics Association (AMIA). Every year, leading informaticians such as – translational scientists, clinicians,…
iConnect 2.0 is a specifically designed online platform that facilitates patient-recruitment for academic medical centers, sponsors, and patient advocacy groups. iConnect 2.0 helps overcome challenges of patient recruitment in clinical trials by: Creating a…